Patent Assignment
Reel/Frame 023586/0215
Patent Assignment
Recorded: 2009-12-01
Pages: 7
Assignor
BAKER BROS. ADVISORS LLC
Executed: 2009-11-06
Assignee
BBDX, INC.
667 MADISON AVENUE, 21ST FLOOR, NEW YORK, NEW YORK, 10065
Covered Properties
(28)
Use of Haptoglobin Genotyping in Diagnosis and Treatment of Defective Reverse Cholesterol Transport (Rct)
PCT:
PCT/US2008/006162 ↗
Liver-Derived Receptors for Advanced Glycosylation Endproducts and Uses Thereof
Patent:
5,585,344 →
Application:
07/749,438 →
Mesangial Cell-Derived Receptors for Advanced Glycosylation Endproducts and Uses Thereof
Patent:
5,202,424 →
Application:
07/749,444 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,624,804 →
Application:
07/956,849 →
Method for Detecting Hemoglobin Advanced Glycosylation Endproducts
Patent:
5,610,076 →
Application:
08/236,416 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,700,447 →
Application:
08/319,747 →
Monoclonal Antibody for the Detection Advanced Glycosylation Endpro- Ducts in Biological
Patent:
5,744,318 →
Application:
08/367,507 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,712,101 →
Application:
08/472,398 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,733,933 →
Application:
08/473,009 →
Immunochemical Isolation of in Vivo Advanced Glycosylation Endproducts
Patent:
5,629,408 →
Application:
08/476,381 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,733,524 →
Application:
08/479,673 →
Monoclonal Antibody Specific for Advanced Glycosylation Endproducts in Biological Samples
Patent:
5,698,197 →
Application:
08/483,186 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,733,546 →
Application:
08/484,869 →
Antibodies to in Vivo Advanced Glycosylation Endproducts
Patent:
5,702,704 →
Application:
08/486,513 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,683,887 →
Application:
08/487,055 →
Monoclonal Antibodies Specific for Advanced Glycosylation Endproducts in Biological Samples
Patent:
5,892,000 →
Application:
08/581,724 →
Monoclonal Antibody Specific for Advanced Glycosylation Endproducts in Biological Samples
Patent:
39,138 →
Application:
09/465,444 →
Method of determing a potential of a hyperglycemic patients of developing vascular complications
Patent:
6,251,608 →
Application:
09/556,469 →
Method of Evaluating a Risk of a Subject of Developing Vascular Complications
Patent:
6,599,702 →
Application:
09/688,121 →
Method of Determining a Risk of Hyperglycemic Patients of Developing a Cardiovascular Disease
Patent:
6,613,519 →
Application:
09/815,016 →
Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic Patients
Application:
10/584,998 →
Publication:
US 2007/0218462
Methods of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hyperglycemic Patients
Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype
Application:
11/798,488 →
Publication:
US 2008/0044399
Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individuals
Application:
12/071,270 →
Publication:
US 2008/0213785
Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)
Application:
12/153,186 →
Publication:
US 2009/0074740
Glycemic Control for Reduction of Cardiovascular Disease Risk in Diabetic Patients Expressing Haptoglobin 2-2
Application:
12/262,384 →
Publication:
US 2009/0246770
Use of Haptoglobin Genotyping in Diagnosis and Treatment of Cardiovascular Disease
Application:
12/276,963 →
Publication:
US 2009/0137617
Reagents and methods for detecting a polymorphic protein
Application:
61/129,250 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Mar 2, 2009
From: SYNVISTA THERAPEUTICS, INC.
To: BAKER BROS. ADVISORS, LLC, AS COLLATERAL AGENT
Reel/Frame 022331/0074 →
Strict Foreclosure in Full Satisfaction of Loan Obligations
Nov 20, 2009
From: SYNVISTA THERAPEUTICS, INC.
To: BAKER BROS. ADVISORS LLC, IN ITS CAPACITY AS COLLATERAL AGENT
Reel/Frame 023546/0531 →
Assignment of Assignor's Interest
Apr 2, 2012
From: BERKOWITZ, NOAH; LEVY, ANDREW P.
To: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
Reel/Frame 027971/0577 →
Assignment of Assignor's Interest
Apr 21, 2016
From: BBDX, INC.
To: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
Reel/Frame 038337/0191 →